Literature DB >> 18030263

Comparison of postsurgical and community acquired bacterial meningitis--analysis of 372 cases within a nationwide survey.

A Streharova1, J Benca, K Holeckova, J Balik, I Sula, A Lesnakova, L Luzinsky, Z Pavlikova, E Adamkovicova, N Spilakova, B Kacunova, V Dovalova, P Kisac, P Beno, E Kalavsky, M Sramka, J Benka, A Ondrusova, S Seckova, V Sladeckova, A Kolenova, M Bartkovjak, P Bukovinova, F Hvizdak, P Lengyel, M Bielova, O Wiczmandyova, V Svabova, L Findova, K Kutna, J Deadline, E Diana, M Krumpolcova, M Kiwou, J Steno, I Stankovic, F Bauer, M Kovac, M Huttova, M Taziarova, R Luzica, B Saniova, B Rudinsky, I Sabo, M Karvaj, M J Johnson.   

Abstract

The aim of this study was to assess if differences in etiology and risk factors among 372 cases of bacterial meningitis acquired after surgery (PM) or in community (CBM) have impact on outcome of infected patients. Among 372 cases of bacterial meningitis within last 17 years from 10 major Slovak hospitals, 171 were PM and 201 CBM. Etiology, risk factors such as underlying disease, cancer, diabetes alcoholism, surgery, VLBW, ENT infections, trauma, sepsis were recorded and mortality, survival with sequellae, therapy failure were compared in both groups. Significant differences in etiology and risk factors between both groups were reported. Those after neurosurgery had more frequently Coagulase negative staphylococci (p<0.001), Enterobacteriaceae (p=0.01) and Acinetobacter baumannii (p=0.0008) isolated from CSF and vice versa Streptococcus pneumoniae (p<0.001), Neisseria meningitis (p<0.001) and Haemophillus influenza (p=0.0009) were more commonly isolated from CSF in CBM. Neurosurgery (p<0.001), sepsis (p=0.006), VLBW neonates (p=0.00002) and cancer (p=0.0007) were more common in PM and alcohol abuse (p<0.001) as well as otitis/sinusitis (p<0.001) and Roma ethnic group (p=0.001) in CAM. Initial treatment success was significantly more frequently observed among CAM (p<0.001) but cure after modification was more common in PM (p=0.002). Therefore outcome in both groups was similar (14.6% vs. 12.4%, p=NS).

Entities:  

Mesh:

Year:  2007        PMID: 18030263

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

1.  Caulobacter species as a cause of postneurosurgical bacterial meningitis in a pediatric patient.

Authors:  Natalie Bridger; Andrew Walkty; Maryanne Crockett; Sergio Fanella; Kim Nichol; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  The causes and treatment outcomes of 91 patients with adult nosocomial meningitis.

Authors:  Hye-In Kim; Shin-Woo Kim; Ga-Young Park; Eu-Gene Kwon; Hyo-Hoon Kim; Ju-Young Jeong; Hyun-Ha Chang; Jong-Myung Lee; Neung-Su Kim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

3.  Intracranial malignant lesions correlate with the requirement for a long treatment course in postoperative central nervous system infection.

Authors:  Heng Zhou; Xinghu Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-04       Impact factor: 2.570

4.  The Organisms and Factors Affecting Outcomes of External Ventricular Drainage Catheter-Related Ventriculitis: A Penang Experience.

Authors:  Jo Ee Sam; Chee Loon Lim; Priya Sharda; Nasser Abdul Wahab
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

5.  The risk of acquiring bacterial meningitis following surgery in Denmark, 1996-2009: a nationwide retrospective cohort study with emphasis on ear, nose and throat (ENT) and neurosurgery.

Authors:  M F Howitz; P Homøe
Journal:  Epidemiol Infect       Date:  2013-08-09       Impact factor: 4.434

6.  Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study.

Authors:  Dahraoui Souhail; Belefquih Bouchra; Badia Belarj; Rar Laila; Frikh Mohammed; Oumarou Mamane Nassirou; Ibrahimi Azeddine; Charki Haimeur; Abdelhay Lemnouer; Mostafa Elouennass
Journal:  Case Rep Infect Dis       Date:  2016-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.